• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体隐性遗传骨硬化症中造血干细胞移植诱导的骨重塑:骨骼与造血及感觉神经系统的相互作用。

Hematopoietic stem cell transplantation-induced bone remodeling in autosomal recessive osteopetrosis: Interaction between skeleton and hematopoietic and sensory nervous systems.

机构信息

Institute for Maternal and Child Health - IRCCS Burlo Garofolo, via dell'Istria 65/1, 34137 Trieste, Italy.

Hôpitaux Pédiatriques de Nice, CHU Lenval, 57 Avenue de la Californie, 06200 Nice, France.

出版信息

Bone. 2020 Jan;130:115144. doi: 10.1016/j.bone.2019.115144. Epub 2019 Nov 6.

DOI:10.1016/j.bone.2019.115144
PMID:31706050
Abstract

OBJECTIVE

Autosomal recessive osteopetrosis (ARO) is a rare congenital disorder of defective bone resorption. The inability of osteoclasts to resorb bone compromises the development of bone marrow cavity, and ultimately, leads to defective hematopoiesis and death within the first decade. The only curative treatment currently available for certain forms of ARO is hematopoietic stem cell transplantation (HSCT). Infants over ten months of age suffering from ARO are defined as patients with advanced disease; HSCT to these patients is associated with high risk of transplant-related mortality (TRM). Because of the extreme variability of ARO clinical phenotypes, the most reliable predictive factor of TRM and graft failure risk is the residual bone marrow space volume.

CASE REPORT

We report clinical and radiological outcomes of one patient affected by ARO and treated with HSCT at advance stage of the disease. We describe the anomalies in various tissues, including bone marrow and bones at the moment of the diagnosis and document their gradual disappearance after HSCT until their complete resolution based on magnetic resonance imaging (MRI) observations. We provided radiological images of the cranial vault bone structure modifications, correlating the radiological appearance of the optical canals and nerves and of the cerebellum with the neurological manifestations of the disease.

CONCLUSIONS

Our results demonstrate that MRI is a highly sensitive technique that provides excellent images of bone marrow space before and after HSCT without exposing children to ionizing radiation. MRI also permits us to evaluate post-transplant skeletal remodeling and the deriving changes in the hematopoietic and sensory system.

摘要

目的

常染色体隐性骨硬化症(ARO)是一种罕见的先天性骨吸收缺陷疾病。破骨细胞无法吸收骨骼,会影响骨髓腔的发育,最终导致造血功能缺陷,并在 10 年内死亡。目前,对于某些形式的 ARO,唯一可行的根治性治疗方法是造血干细胞移植(HSCT)。10 个月以上患有 ARO 的婴儿被定义为晚期疾病患者;这些患者接受 HSCT 与移植相关死亡率(TRM)高相关。由于 ARO 临床表型的极端可变性,TRM 和移植物失败风险的最可靠预测因素是残余骨髓空间体积。

病例报告

我们报告了一例患有 ARO 的患者的临床和放射学结果,该患者在疾病的晚期接受了 HSCT 治疗。我们描述了诊断时各种组织(包括骨髓和骨骼)的异常,并通过磁共振成像(MRI)观察记录了它们在 HSCT 后的逐渐消失,直到完全消失。我们提供了颅骨骨结构改变的放射图像,将视神经管和神经以及小脑的放射表现与疾病的神经表现相关联。

结论

我们的结果表明,MRI 是一种高度敏感的技术,可在不使儿童暴露于电离辐射的情况下提供 HSCT 前后骨髓空间的出色图像。MRI 还使我们能够评估移植后的骨骼重塑以及造血和感觉系统的后续变化。

相似文献

1
Hematopoietic stem cell transplantation-induced bone remodeling in autosomal recessive osteopetrosis: Interaction between skeleton and hematopoietic and sensory nervous systems.常染色体隐性遗传骨硬化症中造血干细胞移植诱导的骨重塑:骨骼与造血及感觉神经系统的相互作用。
Bone. 2020 Jan;130:115144. doi: 10.1016/j.bone.2019.115144. Epub 2019 Nov 6.
2
Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantation.
Pediatr Blood Cancer. 2015 Sep;62(9):1645-9. doi: 10.1002/pbc.25524. Epub 2015 Mar 27.
3
Autosomal recessive osteopetrosis: mechanisms and treatments.常染色体隐性遗传性骨硬化症:发病机制与治疗方法。
Dis Model Mech. 2021 May 1;14(5). doi: 10.1242/dmm.048940. Epub 2021 May 10.
4
Radiography of successful bone marrow transplantation for osteopetrosis.
Skeletal Radiol. 2007 Jun;36 Suppl 1:S34-7. doi: 10.1007/s00256-006-0141-1. Epub 2006 Jun 24.
5
Hematopoietic stem cell transplantation in a patient with osteopetrosis and mutation in CLCN7: long-term follow-up.成骨不全症和 CLCN7 基因突变患者的造血干细胞移植:长期随访。
Bol Med Hosp Infant Mex. 2021 Mar 2;78(3):225-233. doi: 10.24875/BMHIM.20000105.
6
Skeletal Changes After Hematopoietic Stem Cell Transplantation in Osteopetrosis.成骨不全症患者造血干细胞移植后的骨骼变化。
J Bone Miner Res. 2020 Sep;35(9):1645-1651. doi: 10.1002/jbmr.4037. Epub 2020 Jul 12.
7
Allogenic hematopoietic stem cell transplantation in an Iranian patient with osteopetrosis caused by carbonic anhydrase II deficiency: A case report.一名因碳酸酐酶 II 缺乏导致的成骨不全症伊朗患者接受同种异体造血干细胞移植:病例报告。
Pediatr Transplant. 2024 May;28(3):e14689. doi: 10.1111/petr.14689.
8
Prognostic potential of precise molecular diagnosis of Autosomal Recessive Osteopetrosis with respect to the outcome of bone marrow transplantation.常染色体隐性遗传骨硬化症精确分子诊断对骨髓移植结果的预后潜力。
Cytotechnology. 2008 Sep;58(1):57-62. doi: 10.1007/s10616-008-9165-9. Epub 2008 Sep 30.
9
Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation.
Bone Marrow Transplant. 2000 Jul;26(2):219-24. doi: 10.1038/sj.bmt.1702491.
10
Transplantation of cord blood progenitor cells can promote bone resorption in autosomal recessive osteopetrosis.脐血祖细胞移植可促进常染色体隐性骨硬化症中的骨吸收。
Bone Marrow Transplant. 1997 Oct;20(8):701-5. doi: 10.1038/sj.bmt.1700946.

引用本文的文献

1
Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice.骨髓移植作为治疗常染色体显性遗传骨硬化症 2 型的方法在小鼠中。
FASEB J. 2022 Sep;36(9):e22471. doi: 10.1096/fj.202200678R.
2
A Neonatal Case of Infantile Malignant Osteopetrosis Presenting with Thrombocytopenia and Hypotonicity: A Novel Mutation in Chloride Voltage-Gated Channel 7 Gene.一例以血小板减少和肌张力减退为表现的婴儿恶性骨硬化症新生儿病例:氯离子电压门控通道7基因的新突变
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):161-165. doi: 10.14744/SEMB.2021.88964. eCollection 2022.
3
Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.
Ostm1 从鼠到人:破骨细胞成熟的见解。
Int J Mol Sci. 2020 Aug 5;21(16):5600. doi: 10.3390/ijms21165600.